Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Patent
1998-05-01
2000-10-17
Guzo, David
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
435 9131, 4353201, 435325, 435366, 536 231, 536 245, C12Q 168, C07H 2104, C12N 1563, C12N 1585
Patent
active
061329673
ABSTRACT:
Enzymatic RNA molecules which cleave ICAM-1 mRNA.
REFERENCES:
patent: 4987071 (1991-01-01), Cech
patent: 5168053 (1992-12-01), Altman et al.
patent: 5225337 (1993-07-01), Robertson et al.
Branch TIBS 23:45-50, Feb. 1998.
Crooke, Chi "Antisense Research and Application", Springer, N.Y., pp. 1-50, 1998.
Altmann et al., "Cotransfection of ICAM-1 and HLA-DR reconstitutes human antigen-presenting cell function in mouse L cells," Nature 338:512-514 (1989).
Ballantyne et al., "Nucloetide sequence of the cDNA for murine intercellular adhesion molecule-1 (ICAM-1)," Nucleic Acids Research 17:5853 (1989).
Baringa, "Ribozymes: Killing the messenger," Science 262:1512-1514 (1993).
Bowes et al., "Monoclonal antibody to the ICAM-1 adhesion site reduces neurological damage in a rabbit cerebral embolism stroke model," Experimental Neurology 119:215-219 (1993).
Boyd et al., "Intercellular adhesion molecule 1 (ICAM-1) has a central role in cell-cell contact-mediated immune mechanisms," Proc. Natl. Acad. Sci. USA 85:3095-3099 (1988).
Cech, "Ribozymes and their medical implications," JAMA 260:3030-3034 (1988).
Chen et al., "Multitarget-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication-potential effectiveness against most presently sequenced HIV-1 isolates," Nucleic Acids Research 20:4581-4589 (1992).
Chiang et al., "Antisense oligonucleotides inhibit intercellular adhesion molecule 1 expression by two distinct mechanisms," J. Biol. Chem. 27:18162-18171 (1991).
Chin et al., "Role of cytokines in inflammatory synovitis," Arthritis and Rheumatism 33:1776-1786 (1990).
Chowrira et al., "Extensive phosphorothioate substitution yields highly active and nuclease-resistant hairpin ribozymes," Nucleic Acids Res. 20:2835-2840 (1992).
Collins et al., "Reaction conditions and kinetics of self-cleavage of a ribozyme derived from Neurospora vs RNA," Biochemistry 32:2795-2799 (1993).
Cosimi, et al., "In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts," Journal of Immunology 144:4604-4612 (1990).
Cotton, "The in vivo application of ribozymes," TIBTECH 8:174-178 (1990).
Dang et al., "Role of ICAM-1 in antigen presentation demonstrated by ICAM-1 defective mutants," Journal of Immunology 144:4082-4091 (1991).
Dropulic et al., "Functional characterization of a U5 ribozyme: Intracellular suppression of human immunodeficiency virus type I expression," Journal of Virology 66:1432-1441 (1992).
Dustin et al., "Induction IL 1 and interferon-.gamma.: Tissue distribution. Biochemistry, and function of a natural adherence molecule (ICAM-1)," Journal of Immunology 137:245-254 (1986).
Dustin et al., "Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells," J. Cell. Biol. 107:321-331 (1988).
Edgington, "Ribozymes: Stop making sense," Biotechnology 10:256-262 (1992).
Elroy-Stein et al., "Cytoplasmic expression system based on constitutive synthesis of bacteriophage T7RNA polymerase in mammalian cells," Proc. Natl. Acad. Sci. USA 87:6743-6747 (1990).
Flavin et al., "Monoclonal antibodies against intercellular adhesion molecule 1 prolong cardiac allograft survival in cynomolgus monkeys," Transplantation Proceedings 23:533-534 (1991).
Fung et al., WO 91/1580 (Oct. 17, 1991) provided as WPI Abstract. Acc. #91-32522344.
Furukawa et al, "Transient depletion of T cells with bright CD11a/CD18 expression from peripheral circulation during acute kawasaki disease," Scand. J. Immunol. 37:377-380 (1993).
Furukawa et al., "Increased levels of circulating intercellular adhesion molecule 1 in kawasaki disease," Arthritis and Rheumatism 35:672-677 (1992).
Gao et al., "Cytoplasmic expression of a reporter gene by co-delivery of T7 RNA polymerase and T7 promoter sequence with cationic liposomes," Nucleic Acids Res. 21:2867-2872 (1993).
Griffiths et al., "Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflammed skin: Modulation by recombinant gamma interferon and tumor necrosis factor," J. Am. Acad. Dermatol. 20:617-629 (1989).
Guerrier-Takada et al., "The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme," Cell 35:849-857 (1983).
Gundel et al., Clin. Exp. Allergy 22:569-575 (1992).
Hampel et al., "Hairpin catalytic RNA model: Evidence for helices and sequence requirement for substrate RNA," Nucleic Acids Research 18:299-304 (1990).
Hampel et al., "`Hairpin` catalytic RNA model: Evidence for helices and sequence requirement for substrate RNA," Nucleic Acids Research 18:299 (1990).
Hampel et al., "RNA catalytic properties of the minimum (-)sTRSV sequence," Biochemistry 28:4929-4933 (1989).
Haseloff et al., "Simple RNA enzymes with new and highly specific endoribonuclease activities," Nature 334:585-591 (1988).
Haug et al., "A phase I trial of immunosuppression with anit-ICAM-1 (CD54) mAb in renal allograft recipients," Transplantation 55:766-773 (1993).
Hertel et al., "Numbering system for the hammerhead," Nucleic Acids Res. 20:3252 (1992).
Hession et al., WO 90/13300 (Nov. 15, 1990) provided as CA Abstr. Acc. #114(25): 292037g.
Jaeger et al., "Improved predictions of secondary structures for RNA," Proc. Natl. Acad. Sci. USA 86:7706-7710 (1989).
Jeffries et al., "A catalytic 13-mer ribozyme," Nucleic Acids Research 17:1371-1377 (1989).
Johnston et al., "Present status and future prospects for HIV therapies," Science 260:1286-1293 (1993).
Kakimoto et al., "The effect of anti-adhesion molecule antibody on the development of collagen-induced arthritis," Cellular Immunology 142:326-337 (1992).
Kashani-Sabet et al., "Reversal of the malignant phenotype by an anti-ras ribozyme," Antisense Research & Development 2:3-15 (1992).
Kellner et al., "Overexpression of extracellular matrix receptors (VLA-3, 5 and 6) on psoriatic keratinocytes," British Journal of Dermatology 125:211-216 (1991).
Kim et al., Proc. Natl. Acad. Sci. USA 84:8788 (1987).
Kita et al., "Sequence and expression of rat ICAM-1," Biochem Biophys. Acta 1131:108-110 (1992).
Koch et al., "Immunolocalization of endothelial and leukocyte adhesion molecules in human rheumatoid and osteoarthritic synovial tissue," Laboratory Investigation 64:313-320 (1991).
L'Huiller et al., "Cytomplasmic delivery of ribozymes leads to efficient reduction in .alpha.-lactalbumin mRNA levels in C1271 mouse," EMBO J. 11:4411-4418 (1992).
Leung et al., "Endothelial call activation and high interleukin-1 secretion in the pathogenesis of acute kawasaki disease," The Lancet 2:1298-1302 (1989).
Lieber et al., "Stable high-level gene expression in mammalian cells by T7 phage RNA polymerase," Methods Enzymol. 217:47-66 (1993).
Ligo et al., "ICAM-1 dependent pathway is critically involved in the pathogenesis of adjuvant arthritis in rats," Journal of Immunology 147:4167-4171 (1991).
Lisziewicz et al., "Inhibition of human immunodeficiency virus type I replication by regulated expression of a polymeric tat activation response RNA decoy as a strategy for gene therapy in AIDS," Proc. Natl. Acad. Sci. USA 90:8000-8004 (1993).
Ma et al., "Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion," Circulation 86:937-946 (1992).
Mamone et al., "Design of hammerhead ribozymes targeted to sequences in HIV, HSV and the RAT ANF gene," Abstract of Keystone, CO (May 27, 1992).
Mason et al., "Detection of increased levels of circulating intercellular adhesion molecule 1 in some patients with rheumatoid arthritis but not in patients with systemic lupus erythematosus," Arthritis and Rheumatism 36:519-527 (1993).
Nabel et al., "Site-specific gene expression in vivo by direct gene transfer into the arterial wall," Science 249:1285-1288 (1990).
Nickeloff et al., "Accessory cell function of keratinocytes for superantigens," Journal of Immunology 150:2148-2159 (1993).
Ohkawa et al., "Activities of HIV-RNA targeted ribozymes transcribed from a `shot-
Draper Kenneth G.
Grimm Susan
McSwiggen James
Stinchcomb Dan T.
Sullivan Sean
Guzo David
Ribozyme Pharmaceuticals Inc.
Wang Andrew
LandOfFree
Ribozyme treatment of diseases or conditions related to levels o does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ribozyme treatment of diseases or conditions related to levels o, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ribozyme treatment of diseases or conditions related to levels o will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-467010